DXCM
Price
$60.25
Change
+$1.83 (+3.13%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
23.49B
76 days until earnings call
Intraday BUY SELL Signals
INSP
Price
$89.83
Change
+$6.56 (+7.88%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
2.61B
81 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DXCM vs INSP

Header iconDXCM vs INSP Comparison
Open Charts DXCM vs INSPBanner chart's image
DexCom
Price$60.25
Change+$1.83 (+3.13%)
Volume$95.14K
Capitalization23.49B
Inspire Medical Systems
Price$89.83
Change+$6.56 (+7.88%)
Volume$11.78K
Capitalization2.61B
DXCM vs INSP Comparison Chart in %
DXCM
Daily Signal:
Gain/Loss:
INSP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DXCM vs. INSP commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Hold and INSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (DXCM: $60.23 vs. INSP: $89.87)
Brand notoriety: DXCM and INSP are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: DXCM: 79% vs. INSP: 125%
Market capitalization -- DXCM: $23.49B vs. INSP: $2.61B
DXCM [@Medical/Nursing Services] is valued at $23.49B. INSP’s [@Medical/Nursing Services] market capitalization is $2.61B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $222.77B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 1 FA rating(s) are green whileINSP’s FA Score has 0 green FA rating(s).

  • DXCM’s FA Score: 1 green, 4 red.
  • INSP’s FA Score: 0 green, 5 red.
According to our system of comparison, DXCM is a better buy in the long-term than INSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 5 TA indicator(s) are bullish while INSP’s TA Score has 7 bullish TA indicator(s).

  • DXCM’s TA Score: 5 bullish, 3 bearish.
  • INSP’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, INSP is a better buy in the short-term than DXCM.

Price Growth

DXCM (@Medical/Nursing Services) experienced а +3.74% price change this week, while INSP (@Medical/Nursing Services) price change was +4.08% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.32%. For the same industry, the average monthly price growth was -6.15%, and the average quarterly price growth was +9.87%.

Reported Earning Dates

DXCM is expected to report earnings on Feb 05, 2026.

INSP is expected to report earnings on Feb 10, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.32% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($23.5B) has a higher market cap than INSP($2.61B). INSP has higher P/E ratio than DXCM: INSP (61.55) vs DXCM (33.46). DXCM YTD gains are higher at: -22.554 vs. INSP (-51.521). DXCM has higher annual earnings (EBITDA): 1.22B vs. INSP (69.6M). DXCM has more cash in the bank: 3.32B vs. INSP (301M). INSP has less debt than DXCM: INSP (33.1M) vs DXCM (2.58B). DXCM has higher revenues than INSP: DXCM (4.52B) vs INSP (861M).
DXCMINSPDXCM / INSP
Capitalization23.5B2.61B900%
EBITDA1.22B69.6M1,756%
Gain YTD-22.554-51.52144%
P/E Ratio33.4661.5554%
Revenue4.52B861M525%
Total Cash3.32B301M1,104%
Total Debt2.58B33.1M7,782%
FUNDAMENTALS RATINGS
DXCM vs INSP: Fundamental Ratings
DXCM
INSP
OUTLOOK RATING
1..100
6966
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3174
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
7797
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (74) in the Medical Specialties industry is in the same range as INSP (77). This means that DXCM’s stock grew similarly to INSP’s over the last 12 months.

DXCM's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INSP (100). This means that DXCM’s stock grew similarly to INSP’s over the last 12 months.

DXCM's SMR Rating (31) in the Medical Specialties industry is somewhat better than the same rating for INSP (74). This means that DXCM’s stock grew somewhat faster than INSP’s over the last 12 months.

INSP's Price Growth Rating (64) in the Medical Specialties industry is in the same range as DXCM (65). This means that INSP’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's P/E Growth Rating (77) in the Medical Specialties industry is in the same range as INSP (97). This means that DXCM’s stock grew similarly to INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMINSP
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signal:
Gain/Loss:
INSP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RING63.020.51
+0.82%
iShares MSCI Global Gold Miners ETF
HIX4.140.03
+0.73%
Western Asset High Income Fund II
MKAM30.360.15
+0.50%
MKAM ETF
PFRL49.730.05
+0.10%
PGIM Floating Rate Income ETF
NBTR50.88N/A
N/A
Neuberger Berman Total Return Bond ETF

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with ISRG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+3.10%
ISRG - DXCM
46%
Loosely correlated
+1.70%
GKOS - DXCM
45%
Loosely correlated
+4.64%
ALGN - DXCM
44%
Loosely correlated
+7.34%
SYK - DXCM
41%
Loosely correlated
+2.16%
NVST - DXCM
40%
Loosely correlated
+4.08%
More

INSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSP has been loosely correlated with AVNS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then AVNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
+7.93%
AVNS - INSP
43%
Loosely correlated
+4.68%
BRKR - INSP
42%
Loosely correlated
+7.82%
MASI - INSP
37%
Loosely correlated
+4.37%
AZTA - INSP
37%
Loosely correlated
+16.30%
ENOV - INSP
36%
Loosely correlated
+7.23%
More